Reportlinker Adds The Drug Discovery Outsourcing Market

Thursday, May 26, 2011 General News J E 4

NEW YORK, May 26, 2011 announces that a new market research report is available in its catalogue:

The Drug Discovery Outsourcing Market


This report investigates current trends and opportunities affecting decisions on whether or not to outsource drug discovery. Outsourcing to low cost offshore destinations such as China and India are examined in detail. The report also covers a variety of strategic collaborations, academic partnerships and outsourcing opportunities along with case studies.

Features and benefits

* Develop an informed perspective of the drug discovery process including the role of outsourcing.* Understand the pros and cons of drug discovery outsourcing.* Gain an understanding of the current trends and opportunities in global drug discovery outsourcing market.* Compare the leading ten drug discovery service provider's strategies and capabilities.* Assess China and India as drug discovery outsourcing destinations.


As pharma companies relax their conservatism towards drug discovery outsourcing the market, which was valued at $7.4bn in 2009 is expected to increase to $18.5bn by 2015. Among discovery outsourcing services, chemistry services represented the leading category of outsourced drug discovery services generating around $2.9bn in sales, accounting for a market share of 39%. Biological services accounted for $2bn with a market share of 28%, which is expected to increase in the future. The networked pharma model under which companies reduce their footprint of owned facilities in favour of a network of service providers is gaining ground. Virtual companies which outsource almost all research, manufacturing and sales activities are also expected to drive growth in the drug discovery outsourcing market.

Your Key questions answered

* What are the recent trends and opportunities in global drug discovery outsourcing market?* How will drug discovery outsourcing develop in the coming five years?* Which companies will drive the future of global drug discovery outsourcing market?* How is the drug discovery outsourcing market evolving in China and India?* What drug discovery outsourcing strategies are the leading pharmaceutical and biotech companies following?

Executive Summary

Introduction to drug discovery

The contract drug discovery market

Competitive landscape of the global drug discovery outsourcing market

Strategies for drug discovery outsourcing

About the author


Introduction to drug discovery



The drug discovery process

Identifying disease targets

Validation of the target

Assay development and screening process

Lead optimization

The role of CROs in drug discovery

The contract drug discovery market


Pros and cons of drug discovery outsourcing

Pros of outsourcing drug discovery

Cons of outsourcing drug discovery

Key industry trends

From transactional to strategic outsourcing

R&D restructuring in big pharma to create better opportunities for discovery CROs

Divestiture of drug discovery assets to reduce fixed costs

The Asia-Pacific region as an emerging location for drug discovery outsourcing

Rising consolidation in the drug discovery space

Impact of advances in genomics and pharmacogenomics

ADMET studies are a strong growth opportunity for drug discovery CROs

The drug discovery outsourcing market

Market forecast

Description of drug discovery technologies

Drug design

High-throughput screening (HTS)


Combinatorial chemistry

Microfluidics (lab-on-a-chip)

Drug discovery outsourcing to Asia - a continuing phenomenon

Drug discovery outsourcing to China: an overview

Competitive landscape

Drug discovery outsourcing to India: an overview

Competitive landscape

Competitive landscape of global drug discovery outsourcing market



Competitive landscape

Role of academics in drug discovery

Capability analysis of key drug discovery outsourcing companies

Company profiles

Albany Molecular Research (AMRI)



Bridge Laboratories

Caliper Life Sciences

Charles River Laboratories (CRL)



Ricerca Biosciences

WuXi AppTec

Strategies for drug discovery outsourcing



Strategic outsourcing for greater flexibility and better efficiency

Consolidation in the drug discovery CRO industry for greater competitiveness

The "virtual pharma" model is expected to create greater opportunity for discovery CROs

The evolving networked R&D model to become more popular in the future

Selected case-studies

Wyeth and GVK Bio's drug discovery alliance

Lilly and Covance's R&D outsourcing deal

AstraZeneca and WuXi AppTec's HTS outsourcing alliance

Hutchison MediPharma and Lilly, Merck KGaA and Procter & Gamble

Ranbaxy and GSK's drug discovery deal

Nicholas Piramal India Ltd/Lilly and Merck & Co.

Bristol-Myers Squibb's research center in Bangalore with Syngene






To order this report:

Drug Discovery and Development Industry: The Drug Discovery Outsourcing Market

Drug Discovery and Development Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Sequenom Announces Participation at Jefferies 2011...
Reportlinker Adds Technology Transfer Strategies -...